Blog 2018-04-20T04:46:44+00:00

HOPE™ Products for Autism Launch in Australia After Earlier US Debuts in Pennsylvania and Louisiana

October 30th, 2020|Categories: Business|

Zelira Therapeutics Ltd (ASX: ZLD, OTCQB: ZLDAF) just announced that its proprietary cannabinoid medicines, HOPE 1 and HOPE 2are now available by prescription to patients in Australia. [...]